You follow the twists as a decades-old silence finally breaks: a woman has confessed to the 1993 death of a newborn found ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at PacBio (NASDAQ:PACB) and its peers.

The new funding will help the cluster build on initial milestones and to prepare for clinical applications, particularly in cancer.

Heightened immune response to flagellins in commensal gut microbes predicted future CD in healthy first-degree relatives of patients.